Advanced search
Publication Cover
Nanomedicine Volume 19, 2024 - Issue 4
Submit an article Journal homepage
72
Views
0
CrossRef citations to date
0
Altmetric
Editorial

Advanced Nanomedicine Approach of JAK Inhibitors: Supporting Treatment of Rheumatoid Arthritis

Radha Rani1 Department of Pharmaceutics, School of Pharmaceutical Sciences, Delhi Pharmaceutical Sciences & Research University, Pushp Vihar, New Delhi, 110017, IndiaORCID Iconhttps://orcid.org/0000-0003-3889-5308
ORCID Icon,
Neha Raina1 Department of Pharmaceutics, School of Pharmaceutical Sciences, Delhi Pharmaceutical Sciences & Research University, Pushp Vihar, New Delhi, 110017, IndiaORCID Iconhttps://orcid.org/0000-0002-9678-8749
ORCID Icon,
Akhilesh Kumar2 Division of Medicine, ICAR-Indian Veterinary Research Institute Izatnagar, Bareilly, 243122, Uttar Pradesh, IndiaORCID Iconhttps://orcid.org/0000-0001-9601-8819
ORCID Icon,
Piyush K Gupta3 Department of Life Sciences, Sharda School of Basic Sciences & Research, Sharda University, Greater Noida, 201310, Uttar Pradesh, India;4 Department of Biotechnology, Graphic Era (Deemed to be University), Dehradun, Uttarakhand, 248002, India;5 Centre for Development of Biomaterials, Sharda School of Basic Sciences & Research, Sharda University, Greater Noida, 201310, Uttar Pradesh, IndiaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-3346-910X
ORCID Icon &
Madhu Gupta1 Department of Pharmaceutics, School of Pharmaceutical Sciences, Delhi Pharmaceutical Sciences & Research University, Pushp Vihar, New Delhi, 110017, IndiaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-8503-0609
ORCID Icon
Pages 277-280 | Received 08 Oct 2023, Accepted 26 Nov 2023, Published online: 12 Jan 2024

References

  • Ebel AV , O'DellJR. Clinical features, diagnosis, and treatment of rheumatoid arthritis. Physician Assist. Clin.6(1), 41–60 (2021).
  • Rani R , RainaN, SharmaA, KumarP, TulliHS, GuptaM. Advancement in nanotechnology for treatment of rheumatoid arthritis: scope and potential applications. Naunyn Schmiedebergs Arch. Pharmacol.396, 2287–2310 (2023).
  • Morinobu A . JAK inhibitors for the treatment of rheumatoid arthritis. Immunol. Med.43(4), 148–155 (2020).
  • Harrington R , AlNokhatha SA, ConwayR. JAK inhibitors in rheumatoid arthritis: an evidence-based review on the emerging clinical data. J. Inflamm. Res.13, 519–531 (2020).
  • Schwartz DM , KannoY, VillarinoA, WardM, GadinaM, O'SheaJJ. JAK inhibition as a therapeutic strategy for immune and inflammatory diseases. Nat. Rev. Drug Discov.16(12), 843–862 (2017).
  • Heidari B . Rheumatoid arthritis: early diagnosis and treatment outcomes. Caspian J. Int. Med.2(1), 161 (2011).
  • Shen Q , ShuH, XuX, ShuG, DuY, YingX. Tofacitinib citrate-based liposomes for effective treatment of rheumatoid arthritis. Die Pharmazie-Int. J. Pharm. Sci.75(4), 131–135 (2020).
  • Wang L , CheK, LiuY. Pharmacokinetics, distribution and efficacy of triptolide PLGA microspheres after intra-articular injection in a rat rheumatoid arthritis model. Xenobiotica51(6), 703–715 (2021).
  • Aldawsari MF , AlhowailAH, AnwerMK, AhmedMM. Development of Diphenyl carbonate-crosslinked cyclodextrin based nanosponges for oral delivery of baricitinib: formulation, characterization and pharmacokinetic studies. Int. J. Nanomed.18, 2239–2251 (2023).
  • Radu A-F , BungauSG. Nanomedical approaches in the realm of rheumatoid arthritis. Ageing Res. Rev.87, 101927 (2023).
  • Bashir S , AamirM, SarfarazRMet al. Fabrication, characterization and in vitro release kinetics of tofacitinib-encapsulated polymeric nanoparticles: a promising implication in the treatment of rheumatoid arthritis. Int. J. Polym. Mater. Polym. Biomater.70(7), 449–458 (2021).
  • Shen Q , HuQ, TangTet al. ICAM-1 targeted thermal-sensitive micelles loaded with tofacitinib for enhanced treatment of rheumatoid arthritis via microwave assistance. Biomater. Adv.138, 212940 (2022).
  • Gorantla S , PuppalaER, NaiduV, SahaRN, SinghviG. Hyaluronic acid-coated proglycosomes for topical delivery of tofacitinib in rheumatoid arthritis condition: formulation design, in vitro, ex vivo characterization, and in vivo efficacy studies. Int. J. Biol. Macromol.224, 207–222 (2023).
  • Gorantla S , PuppalaER, NaiduV, SahaRN, SinghviG. Design of chondroitin sulphate coated proglycosomes for localized delivery of tofacitinib for the treatment of rheumatoid arthritis. Eur. J. Pharm. Biopharm.186, 43–54 (2023).
  • Wang Z , ZhanC, ZengF, WuS. A biopolymer-based and inflammation-responsive nanodrug for rheumatoid arthritis treatment via inhibiting JAK-STAT and JNK signalling pathways. Nanoscale12(45), 23013–23027 (2020).
  • Ansari MJ , AlshahraniSM. Nano-encapsulation and characterization of baricitinib using poly-lactic-glycolic acid co-polymer. Saudi Pharm. J.27(4), 491–501 (2019).
  • Li Y , LiB, WangGet al. Engineered protein and Jakinib nanoplatform with extraordinary rheumatoid arthritis treatment. Nano Res.16, 1–9 (2023).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.